Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans
Clinical trial NCT07646080 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07646080
- Sponsor
- Yanjie Zhang, MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2028-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.